Role of cell cycle in mediating sensitivity to radiotherapy.
By T. Pawlik, K. Keyomarsi. International Journal of Radiation Oncology, Biology, Physics, 2004
1,079 citations recorded by the source corpus.
Subfields: Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/d4a9dd7ee68f47baae53bd73e107fd7210e83f9b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- John N. Weinstein
- Abdel Kareem Azab
- Katherine A. Hoadley
- William Y. Kim
- F. Azab
- E. Gibb
- Barbara Muz
- Pilar de la Puente
In Oncology
Citations in the corpus
- A Consensus Molecular Classification of Muscle-invasive Bladder Cancer (2019, background): “In contrast, NE-like and LumU tumors both had profiles associated with a potential response to radiotherapy [32,33], showing elevated cell cycle activity (pNElike< 0.”
- The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy (2015, background): “It was shown that cells exposed to ionizing radiation are the least sensitive at the end of S phase, less sensitive in the G1 phase, and the most radiosensitive in the G2/M phase where DNA repair mechanisms are the most prone to malfunction.(100) Hence, anticancer treatments, both radio- and chemoth”
- Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements☆ (2017, background): “While cells in late G2 andmitosis are the most radiosensitive, cells in late S phase are themost radioresistant [103].”